Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
There is a good amount of evidence that exposure therapy is an effective treatment for posttraumatic stress disorder (PTSD). Notwithstanding its efficacy, there is room for improvement, since a large proportion of patients does not benefit from treatment. Recently, an interesting new direction in the improvement of exposure therapy efficacy for PTSD emerged. Basic research found evidence of the pharmacological enhancement of the underlying learning and memory processes of exposure therapy. The current review aims to give an overview of clinical studies on pharmacological enhancement of exposure-based treatment for PTSD. The working mechanisms, efficacy studies in PTSD patients, and clinical utility of four different pharmacological enhancers will be discussed: d-cycloserine, MDMA, hydrocortisone, and propranolol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multidimensional Meta-Analysis of Psychotherapy for PTSD
Bradley, R., Greene, J., Russ, E., Dutra, L., & Westen, D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.214 · Cited by 1,938
Context, time, and memory retrieval in the interference paradigms of Pavlovian learning
Bouton, M. E. (1993) · Psychological Bulletin · doi:10.1037/0033-2909.114.1.80 · Cited by 1,896
Phelps, E. A., Delgado, M. R., Nearing, K. I., & LeDoux, J. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.042 · Cited by 1,753
LeDoux, J. E. (1995) · Annual Review of Psychology · doi:10.1146/annurev.ps.46.020195.001233 · Cited by 1,646 · cited 1×
“It is believed that with extinction learning a new association (CS-noUS) is formed and consolidated, while the original fear-memory stays intact (Bouton, 1993; LeDoux, 1995).”
Optimizing inhibitory learning during exposure therapy
Craske, M. G., Kircanski, K., Zelikowsky, M., Mystkowski, J., Chowdhury, N., & Baker, A. (2008) · Behaviour Research and Therapy · doi:10.1016/j.brat.2007.10.003 · Cited by 1,607
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Memory Reconsolidation and Extinction Have Distinct Temporal and Biochemical Signatures
Suzuki, A., Josselyn, S. A., Frankland, P. W., Masushige, S., Silva, A. J., & Kida, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5491-03.2004 · Cited by 1,127
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
Self-citationProlonged Exposure Therapy for PTSD: Therapist Guide: Emotional processing of traumatic experiences
Foa, E. B., Hembree, E., & Rothbaum, B. (2007) · doi:10.1093/med:psych/9780195308501.001.0001 · Cited by 1,050
Self-citationA meta-analytic review of prolonged exposure for posttraumatic stress disorder
Powers, M. B., Halpern, J. M., Ferenschak, M. P., Gillihan, S. J., & Foa, E. B. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.04.007 · Cited by 1,005
Foa, E. B., Hembree, E. A., Cahill, S. P., Rauch, S. A. M., Riggs, D. S., Feeny, N. C., & Yadin, E. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.5.953 · Cited by 931 · cited 1×
“In an attempt to improve treatment efficacy, some researchers added other psychological interventions to exposure therapy, such as cognitive restructuring (Foa et al., 2005; Resick et al., 2008) or imaginal rescripting (Arntz, Tiesema, & Kindt, 2007).”
Beyond extinction: erasing human fear responses and preventing the return of fear
Kindt, M., Soeter, M., & Vervliet, B. (2009) · Nature Neuroscience · doi:10.1038/nn.2271 · Cited by 826
Resick, P. A., Galovski, T. E., Uhlmansiek, M. O., Scher, C. D., Clum, G. A., & Young-Xu, Y. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.76.2.243 · Cited by 825
Walker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02343.2002 · Cited by 815
Schnurr, P. P., Friedman, M. J., Engel, C. C., Foa, E. B., Shea, M. T., Chow, B. K., Resick, P. A., Thurston, V., Orsillo, S. M., Haug, R., et al. (2007) · JAMA · doi:10.1001/jama.297.8.820 · Cited by 813 · cited 4×
“Clinical trials have shown that approximately 50% of patients lose their PTSD diagnosis after exposure therapy and that the proportion of patients achieving complete remission is even smaller (Bradley, Greene, Russ, Dutra, & Westen, 2005; Schnurr et al., 2007).”
InfluentialMithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378371 · Cited by 674
Dębiec, J., & Ledoux, J. E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.018 · Cited by 602
Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder
Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. M., Pollack, M. H., Eisenmenger, K., Shiekh, M., & Otto, M. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.298 · Cited by 560 · cited 4×
“, 2012) or other anxiety disorders (Hofmann et al., 2006; Kushner et al., 2007; Storch et al., 2007).”
InfluentialBrunet, A., Orr, S. P., Tremblay, J., Robertson, K., Nader, K., & Pitman, R. K. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.05.006 · Cited by 548
A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy
Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.012 · Cited by 510 · cited 4×
“Discussion Granted that DCS was found to enhance exposure therapy across anxiety disorders (Bontempo et al., 2012; Norberg et al., 2008), so far findings in PTSD populations are inconclusive.”
InfluentialImplications of memory modulation for post-traumatic stress and fear disorders
Parsons, R. G., & Ressler, K. J. (2013) · Nature Neuroscience · doi:10.1038/nn.3296 · Cited by 476
Temporally graded requirement for protein synthesis following memory reactivation
Milekic, M. H., & Alberini, C. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00976-5 · Cited by 455 · cited 1×
“…in reconsolidation blockage in PTSD patients, based on research findings that older memories are more difficult to influence after retrieval (Milekic & Alberini, 2002) and that repeated retrieval (i.e., re-experiences) can strengthen fear memories and make them more resistant to extinction…”
Effects of D-cycloserine on extinction of conditioned freezing.
Ledgerwood, L., Richardson, R., & Cranney, J. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.2.341 · Cited by 388
A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research
MacDonald, E., Dadds, M. R., Brennan, J. L., Williams, K., Levy, F., & Cauchi, A. J. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.02.015 · Cited by 359 · cited 2×
“The alternative of oxytocin enhancement may have better clinical utility, considering that it is easily administered e.g., as a nasal spray and produces little adverse effects (MacDonald et al., 2011).”
Mills, K. L., Teesson, M., Back, S. E., Brady, K. T., Baker, A. L., Hopwood, S., Sannibale, C., Barrett, E. L., Merz, S., Rosenfeld, J., et al. (2012) · JAMA · doi:10.1001/jama.2012.9071 · Cited by 339 · cited 1×
“Although alcohol abuse is not considered to be a contra-indication for exposure treatment in PTSD patients (Mills et al., 2012; van Minnen, Harned, Zoellner, & Mills, 2012) the potential hazardous drug-drug interactions call for caution.”
Brunet, A., Poundja, J., Tremblay, J., Bui, É., Thomas, É., Orr, S. P., Azzoug, A., Birmes, P., & Pitman, R. K. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318222f360 · Cited by 331
Efficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder
Otto, M. W., Tolin, D. F., Simon, N. M., Pearlson, G. D., Basden, S., Meunier, S. A., Hofmann, S. G., Eisenmenger, K., Krystal, J. H., & Pollack, M. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.036 · Cited by 251
Examining potential contraindications for prolonged exposure therapy for PTSD
van Minnen, A., Harned, M. S., Zoellner, L., & Mills, K. (2012) · European Journal of Psychotraumatology · doi:10.3402/ejpt.v3i0.18805 · Cited by 248
Liechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00148-7 · Cited by 248
Reconsolidation in a human fear conditioning study: A test of extinction as updating mechanism
Kindt, M., & Soeter, M. (2013) · Biological Psychology · doi:10.1016/j.biopsycho.2011.09.016 · Cited by 240
Thompson, M. R., Callaghan, P. D., Hunt, G. E., Cornish, J. L., & McGregor, I. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.032 · Cited by 237
Lonergan, M. H., Olivera-Figueroa, L. A., Pitman, R. K., & Brunet, A. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120111 · Cited by 237
Camí, J., Farré, M., Mas, M., Roset, P. N., Poudevida, S., Mas, A., San, L., & de la Torre, R. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00010 · Cited by 234 · cited 1×
“The drug has profound subjective effects as feelings of euphoria and well-being, heightened senses, and closeness to others (Cami et al., 2000; Kolbrich et al., 2008).”
de Kleine, R. A., Hendriks, G.-J., Kusters, W. J. C., Broekman, T. G., & van Minnen, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.02.033 · Cited by 220 · cited 2×
“Only a few studies were randomized clinical trials with adequate blinding and sample size [DCS: De Kleine et al. (2012); Litz et al. (2012); MDMA: Oehen et al. (2013)].”
BackgroundD-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder
Storch, E. A., Merlo, L. J., Bengtson, M., Murphy, T. K., Lewis, M. H., Yang, M. C., Jacob, M. L., Larson, M., Hirsh, A., Fernandez, M., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32819f8480 · Cited by 200 · cited 2×
“, 2012) or other anxiety disorders (Hofmann et al., 2006; Kushner et al., 2007; Storch et al., 2007).”
Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications
Richardson, R., Ledgerwood, L., & Cranney, J. (2004) · Learning & Memory · doi:10.1101/lm.78204 · Cited by 185
A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear
Guastella, A. J., Dadds, M. R., Lovibond, P. F., Mitchell, P., & Richardson, R. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.006 · Cited by 164
van Minnen, A., & Hagenaars, M. (2002) · Journal of Traumatic Stress · doi:10.1023/a:1020177023209 · Cited by 154 · cited 1×
“…DCS only after successful sessions, research on the predictive value of within session extinction for overall treatment outcome is indecisive (Craske et al., 2008; van Minnen & Hagenaars, 2002), and the question what exactly defines a successful exposure session has yet to be answered.”
A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
Dumont, G. J. H., & Verkes, R. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063271 · Cited by 149 · cited 2×
“Further, neurotoxicity has been demonstrated in animals, and suggested in humans, but functional impairment in humans has not been convincingly related to MDMA (Dumont & Verkes, 2006).”
MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions
Hysek, C. M., Domes, G., & Liechti, M. E. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2645-9 · Cited by 144
Smits, J. A. J., Rosenfield, D., Otto, M. W., Powers, M. B., Hofmann, S. G., Telch, M. J., Pollack, M. H., & Tart, C. D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.009 · Cited by 142 · cited 2×
“But, the first trials in humans failed to find beneficial effects of postsession administered DCS (Tart et al., 2013), except in those patients who showed good within session habituation (Smits et al., 2013).”
A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder
Olff, M., Langeland, W., Witteveen, A., & Denys, D. (2010) · CNS Spectrums · doi:10.1017/s109285290000047x · Cited by 135
How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale
Johansen, P., & Krebs, T. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102787 · Cited by 96 · cited 2×
“…MDMA (93,4-methylenedioxymethamphetamine) is a substituted phenetylamine and binds and reverses monoamine transporters, resulting in serotonin release and activation of the 5-HT receptor, and to a lesser extent to the release of norepinephrine and dopamine (Johansen & Krebs, 2009; Sessa, 2008).”
Augmentation of exposure therapy with post-session administration of D-cycloserine
Tart, C. D., Handelsman, P. R., DeBoer, L. B., Rosenfield, D., Pollack, M. H., Hofmann, S. G., Powers, M. B., Otto, M. W., & Smits, J. A. J. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.09.024 · Cited by 75
Bontempo, A., Panza, K. E., & Bloch, M. H. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07356 · Cited by 69 · cited 4×
“Discussion Granted that DCS was found to enhance exposure therapy across anxiety disorders (Bontempo et al., 2012; Norberg et al., 2008), so far findings in PTSD populations are inconclusive.”
Influential
Cited by
Post-traumatic stress disorder.
Yehuda, R., Hoge, C. W., McFarlane, A. C., Vermetten, E., Lanius, R. A., Nievergelt, C. M., Hobfoll, S. E., Koenen, K. C., Neylan, T. C., & Hyman, S. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.57 · Cited by 870
Revisiting propranolol and PTSD: Memory erasure or extinction enhancement?
Giustino, T. F., Fitzgerald, P. J., & Maren, S. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.01.009 · Cited by 137
Intranasal Oxytocin Normalizes Amygdala Functional Connectivity in Posttraumatic Stress Disorder
Koch, S. B. J., van Zuiden, M., Nawijn, L., Frijling, J. L., Veltman, D. J., & Olff, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.1 · Cited by 132
Hendriks, L., Kleine, R. A. D., Broekman, T. G., Hendriks, G.-J., & Minnen, A. V. (2018) · European Journal of Psychotraumatology · doi:10.1080/20008198.2018.1425574 · Cited by 121
Self-citationFlanagan, J. C., Sippel, L. M., Wahlquist, A., Moran-Santa Maria, M. M., & Back, S. E. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.12.014 · Cited by 117
Metadata
- Authors
- de Kleine, R. A., Rothbaum, B. O., & van Minnen, A.
- Venue
- European Journal of Psychotraumatology
- Publisher
- Informa UK Limited
- Published
- 2013-10-17
- Volume
- 4
- Issue
- 1
- ISSN
- 2000-8066 (ISSN-L)
- OpenAlex
- W2056647650
- Cited by
- 67
- References
- 45
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.